EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells

Tadahisa Sugiura iD, Dhienda C Shahannaz iD, Brandon E Ferrell

International Journal of Molecular Sciences · 26.05.2024 · 25 (11) · 5772

DOI: 10.3390/ijms25115772 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.05.2024. Verfasst von Tadahisa Sugiura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY 10467, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocytes, Cardiac, Regenerative Medicine, Heart Failure. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is a life-threatening disorder and is treated by drug therapies and surgical interventions such as heart transplantation and left ventricular assist device (LVAD). However, these treatments can lack effectiveness in the long term and are associated with issues such as donor shortage in heart transplantation, and infection, stroke, or gastrointestinal bleeding in LVADs. Therefore, alternative therapeutic strategies are still needed. In this respect, stem cell therapy has been introduced for the treatment of HF and numerous preclinical and clinical studies are employing a range of stem cell varieties. These stem cells, such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), have been shown to improve cardiac function and attenuate left ventricular remodeling. IPSCs, which have a capacity for unlimited proliferation and differentiation into cardiomyocytes, are a promising cell source for myocardial regeneration therapy. In this review, we discuss the following topics: (1) what are iPSCs; (2) the limitations and solutions for the translation of iPSC-CMs practically; and (3) the current therapeutic clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsMyocytes, CardiacRegenerative MedicineHeart FailureHumansAnimalsRegenerationStem Cell TransplantationCell Differentiation

Stichwörter der Autor:innen

cardiac regenerative therapyheart failureinduced pluripotent stem cellstem cell therapy

Autor:innen und Institutionen

  • Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY 10467, USA.

ORCID-Profile: Tadahisa Sugiura, Dhienda C Shahannaz

Zitieren

APA

Sugiura, T., Shahannaz, D. C., & Ferrell, B. E. (2024). Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells. International Journal of Molecular Sciences, 25(11), 5772. https://doi.org/10.3390/ijms25115772

Vancouver

Sugiura T, Shahannaz DC, Ferrell BE. Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells. International Journal of Molecular Sciences. 2024;25(11):5772. doi:10.3390/ijms25115772

BibTeX
@article{Sugiura2024,
  author = {Sugiura, Tadahisa and Shahannaz, Dhienda C and Ferrell, Brandon E},
  title = {Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {11},
  pages = {5772},
  doi = {10.3390/ijms25115772}
}
Kostenlos starten →